Compass Therapeutics Presents Novel Biomarker Data Related to CTX-471 Clinical Activity at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting
08 nov. 2024 10h05 HE
|
Compass Therapeutics
New data showed a correlation between the levels of neural cell adhesion molecule (NCAM or CD56) expression and response and disease control in patients treated with CTX-471 monotherapy.Predictive...
Compass Minerals International, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
17 juin 2024 13h57 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International,...
Compass Minerals International, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
11 juin 2024 11h52 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 11, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International,...
Compass Minerals International, Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm
06 juin 2024 14h22 HE
|
Portnoy Law
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International,...
NorthStar Moving’s Virtual Food Drive Assists U.S. County with Highest Child Hunger Rate
03 juin 2024 09h00 HE
|
NorthStar Moving Company
Los Angeles, CA, June 03, 2024 (GLOBE NEWSWIRE) -- NorthStar Moving® Company, the leading eco-luxury mover in California, announced today the launch of their 12th Annual Let’s Send Hunger Packing...
Compass Therapeutics to Present Phase 1 Data for CTX-471, A Novel CD137 Agonist Antibody, Demonstrating Anti-Tumor Activity in Patients Who Have Progressed on Approved PD-1 or PD-L1 Inhibitors at the American Society of Clinical Oncology (ASCO) Annual Meeting 2024
23 mai 2024 17h05 HE
|
Compass Therapeutics
CTX-471, a novel anti-CD137 agonist antibody, demonstrated anti-tumor activity in the Company’s Phase 1 Dose Escalation and Dose Expansion, first-in-human monotherapy study in patients with metastatic...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lincoln, Compass Minerals, Exscientia, and Akero and Encourages Investors to Contact the Firm
16 mai 2024 22h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, and Compass Minerals and Encourages Investors to Contact the Firm
12 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, Compass Minerals, and Malibu Boats and Encourages Investors to Contact the Firm
08 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, Compass Minerals, and Malibu Boats and Encourages Investors to Contact the Firm
04 mai 2024 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of...